1208 related articles for article (PubMed ID: 15261928)
21. Comparison of the usefulness of N-terminal pro-brain natriuretic peptide to other serum biomarkers as an early predictor of ST-segment recovery after primary percutaneous coronary intervention.
Verouden NJ; Haeck JD; Kuijt WJ; van Geloven N; Koch KT; Henriques JP; Baan J; Vis MM; van Straalen JP; Fischer J; Piek JJ; Tijssen JG; de Winter RJ
Am J Cardiol; 2010 Apr; 105(8):1047-52. PubMed ID: 20381651
[TBL] [Abstract][Full Text] [Related]
22. Derived fibrinogen compared with C-reactive protein and brain natriuretic peptide for predicting events after myocardial infarction and coronary stenting.
Ketch TR; Turner SJ; Sacrinty MT; Lingle KC; Applegate RJ; Kutcher MA; Sane DC
Am Heart J; 2008 Aug; 156(2):234-40. PubMed ID: 18657651
[TBL] [Abstract][Full Text] [Related]
23. Changes in BNP, hs-CRP and TIMI risk index with addition of tirofiban during primary percutaneous coronary intervention for acute STEMI: a prospective observational cohort study.
Kurt IH; Demirkol S; Ünal I; Batur MK
Anadolu Kardiyol Derg; 2012 Mar; 12(2):107-14. PubMed ID: 22281789
[TBL] [Abstract][Full Text] [Related]
24. Relative role of NT-pro BNP and cardiac troponin T at 96 hours for estimation of infarct size and left ventricular function after acute myocardial infarction.
Steen H; Futterer S; Merten C; Jünger C; Katus HA; Giannitsis E
J Cardiovasc Magn Reson; 2007; 9(5):749-58. PubMed ID: 17891611
[TBL] [Abstract][Full Text] [Related]
25. B-type natriuretic peptide and assessment of jeopardised myocardium in acute myocardial infarction.
Vorlat A; Claeys MJ; Bosmans JM; Van Hoof V; Vrints CJ
Int J Cardiol; 2007 Jan; 114(1):46-9. PubMed ID: 16644042
[TBL] [Abstract][Full Text] [Related]
26. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
[TBL] [Abstract][Full Text] [Related]
27. Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease: a TACTICS-TIMI-18 substudy.
Dokainish H; Pillai M; Murphy SA; DiBattiste PM; Schweiger MJ; Lotfi A; Morrow DA; Cannon CP; Braunwald E; Lakkis N;
J Am Coll Cardiol; 2005 Jan; 45(1):19-24. PubMed ID: 15629367
[TBL] [Abstract][Full Text] [Related]
28. Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial).
Bonaca MP; Wiviott SD; Sabatine MS; Buros J; Murphy SA; Scirica BM; Rifai N; Antman EM; Morrow DA
Am J Cardiol; 2007 Feb; 99(3):344-8. PubMed ID: 17261395
[TBL] [Abstract][Full Text] [Related]
29. Comparison of prognostic value of epicardial blood flow and early ST-segment resolution after primary coronary angioplasty. ANIN--Myocardial Infarction Registry.
Kalińczuk Ł; Przyłuski J; Karcz M; Petryka J; Kaczmarska E; Bekta P; Kepka C; Kruk M; Pregowski J; Kadziela J; Deptuch T; Skwarek M; Cedro K; Ciszewski M; Debski A; Ciszewski A; Chmielak Z; Demkow M; Witkowski A; Ruzyłło W
Kardiol Pol; 2007 Jan; 65(1):1-10; discussion 11-2. PubMed ID: 17295155
[TBL] [Abstract][Full Text] [Related]
30. High levels of N-terminal pro B-type natriuretic peptide are associated with ST resolution failure after reperfusion for acute myocardial infarction.
Lorgis L; Zeller M; Dentan G; Sicard P; Jolak M; L'Huillier I; Vincent-Martin M; Beer JC; Makki H; Gambert P; Cottin Y;
QJM; 2007 Apr; 100(4):211-6. PubMed ID: 17434911
[TBL] [Abstract][Full Text] [Related]
31. Application of the Thrombolysis in Myocardial Infarction risk index in non-ST-segment elevation myocardial infarction: evaluation of patients in the National Registry of Myocardial Infarction.
Wiviott SD; Morrow DA; Frederick PD; Antman EM; Braunwald E;
J Am Coll Cardiol; 2006 Apr; 47(8):1553-8. PubMed ID: 16630990
[TBL] [Abstract][Full Text] [Related]
32. [Brain natriuretic peptide in patients with ST segment elevation myocardial infarction. Prognostic significance].
Dzhaiani NA; Kochetov AG; Kositsyna IV; Golubev AV; Uskach TM; Tereshchenko SN
Ter Arkh; 2006; 78(4):21-6. PubMed ID: 16821416
[TBL] [Abstract][Full Text] [Related]
33. Admission N-terminal pro-brain natriuretic peptide and its interaction with admission troponin T and ST segment resolution for early risk stratification in ST elevation myocardial infarction.
Björklund E; Jernberg T; Johanson P; Venge P; Dellborg M; Wallentin L; Lindahl B;
Heart; 2006 Jun; 92(6):735-40. PubMed ID: 16251228
[TBL] [Abstract][Full Text] [Related]
34. [The examination of clinical prognostic importance of atrial and brain natriuretic peptide in patients with acute myocardial infarction].
Mazurek W; Salomon P
Pol Merkur Lekarski; 2002 Jan; 12(67):15-9. PubMed ID: 11957795
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and prognostic implications of ST-segment deviations from ambulatory Holter monitoring after ST-segment elevation myocardial infarction treated with either fibrinolysis or primary percutaneous coronary intervention (a Danish Trial in Acute Myocardial Infarction-2 Substudy).
Idorn L; Høfsten DE; Wachtell K; Mølgaard H; Egstrup K;
Am J Cardiol; 2007 Sep; 100(6):937-43. PubMed ID: 17826373
[TBL] [Abstract][Full Text] [Related]
36. N-terminal pro-B-type natriuretic peptide is better than TIMI risk score at predicting death after acute myocardial infarction.
Khan SQ; Quinn P; Davies JE; Ng LL
Heart; 2008 Jan; 94(1):40-3. PubMed ID: 17488769
[TBL] [Abstract][Full Text] [Related]
37. Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction.
Gibson CM; Pride YB; Buros JL; Lord E; Shui A; Murphy SA; Pinto DS; Zimetbaum PJ; Sabatine MS; Cannon CP; Josephson ME;
J Am Coll Cardiol; 2008 Feb; 51(5):546-51. PubMed ID: 18237683
[TBL] [Abstract][Full Text] [Related]
38. Postprocedural hyperglycemia in ST elevation myocardial infarction submitted to percutaneous coronary intervention: a prognostic indicator and a marker of metabolic derangement.
Lazzeri C; Chiostri M; Sori A; Valente S; Gensini GF
J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):7-13. PubMed ID: 19829142
[TBL] [Abstract][Full Text] [Related]
39. Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy.
Lindahl B; Lindbäck J; Jernberg T; Johnston N; Stridsberg M; Venge P; Wallentin L
J Am Coll Cardiol; 2005 Feb; 45(4):533-41. PubMed ID: 15708700
[TBL] [Abstract][Full Text] [Related]
40. Soluble CXCL16 predicts long-term mortality in acute coronary syndromes.
Jansson AM; Aukrust P; Ueland T; Smith C; Omland T; Hartford M; Caidahl K
Circulation; 2009 Jun; 119(25):3181-8. PubMed ID: 19528340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
